BNR Udyog (530809)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹96.2 |
| Market Cap | ₹28.86 Cr |
| P/E Ratio | 0 |
| ROCE | -10.04% |
| ROE | -3.83% |
| Dividend Yield | 0% |
| Profit Growth | 63.64% |
| Debt/Equity | — |
| Sales Growth | 8.77% |
| 52-Week Range | ₹28 — ₹96.2 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹34.87 |
Strengths
- Revenue growth of 8.77% shows some business traction.
- Piotroski F-Score of 6/9 indicates moderate balance-sheet health, not a distressed balance sheet.
- Latest quarterly sales of ₹1 crore with net profit at ₹-0 crore suggests losses are razor-thin and close to breakeven.
- Book value of ₹34.87 per share provides tangible asset backing, though current price is above it.
Concerns
- P/E of 0.00 with no positive earnings; ROE of -3.83% and ROCE of -10.04% show capital destruction.
- At ₹96.20, price is 2.76 times book value and market cap is ₹29 crore against quarterly sales of just ₹1 crore—a rich valuation.
- Profit growth of 63.64% is misleading because it starts from a negligible or unprofitable base.
- No dividend, no promoter holding data, and a 243% rally from ₹28 to ₹96.20 signal speculation and opacity.
AI Analysis
Let me start with the simple truth: I can only value a business if I understand its economics, and BNR Udyog's numbers do not yet show economics worth owning. It operates in BPO/KPO, a highly competitive field where pricing power is scarce. This is not a business with an obvious moat. The latest quarter shows sales of ₹1 crore and a net profit of negative zero—essentially a loss. With ROE at -3.83% and ROCE at -10.04%, the company is destroying capital, not compounding it. A P/E of 0.00 is a red flag, not a bargain signal; there are no earnings for me to buy. Some might point to profit growth of 63.64% and claim a turnaround. I would remind them that percentage improvement from a negative or negligible base means little. Revenue did grow 8.77%, and a Piotroski F-score of 6/9 indicates moderate balance-sheet health, so this is not a broken balance sheet. The absence of debt data is a concern, but the real issue is valuation. At ₹96.20, the market capitalises this tiny business at ₹29 crore, roughly 2.76 times book value of ₹34.87. The stock has run from ₹28 to ₹96.20 in 52 weeks—a 243% speculative surge. With no dividend and no promoter holding disclosed, I have little margin of safety. This is a possible turnaround, but only if operations cross into consistent profitability. As Benjamin Graham said, price is what you pay, value is what you get. I would wait for positive ROE, a real earnings stream, and a price that respects the small asset base before I part with my money.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer